Search

Your search keyword '"Macular degeneration -- Reports"' showing total 762 results

Search Constraints

Start Over You searched for: Descriptor "Macular degeneration -- Reports" Remove constraint Descriptor: "Macular degeneration -- Reports"
762 results on '"Macular degeneration -- Reports"'

Search Results

251. Research from Columbia University in Cataracts Provides New Insights

252. Researchers from University of Miami, Bascom Palmer Eye Institute detail new studies and findings in the area of proteomics

253. Studies from National Eye Institute in the area of cholesterol described

254. Scientists at Second Military Medical University, Department of Ophthalmology discuss research in intercellular signaling peptides and proteins

255. Researchers at University of California, Jules Stein Eye Institute release new data on stargardt disease

256. Chapter 5 Global trends in functional foods by health concern

257. New Retinopathy Study Findings Have Been Reported by Researchers at Pomeranian Medical University (New insight into the role of the complement in the most common types of retinopathy-current literature review)

258. New Tumor Necrosis Factors Study Findings Recently Were Reported by N. Angayarkanni and Co-Researchers (Chebulagic acid Chebulinic acid and Gallic acid, the active principles of Triphala, inhibit TNF alpha induced pro-angiogenic and ...)

259. Findings from University of Kiel Broaden Understanding of Clinical and Experimental Ophthalmology (Subjective evaluation of visual acuity is not reliable to detect disease activity in different exudative maculopathies)

260. Researchers from National Center for Scientific Research (CNRS) Discuss Findings in Ophthalmology [Real study: Re-treatment evaluated on visual acuity for Lucentis [R] in neovascular AMD]

262. Researchers from medignition Inc Report Findings in Age-Related Macular Degeneration (Accuracy of a Self-monitoring Test for Identification and Monitoring of Age-related Macular Degeneration: A Diagnostic Case-control Study)

263. Report from Europe

264. RNIB study: obesity doubles risk of AMD

266. Ophthalmology Drug Development Pipeline Review, Market 2016 - Hexa Reports

267. Ophthalmology Drug Industry Development and Pipeline Review, 2016 | Market Research Report By Hexa Reports

268. Ophthalmology Drug Industry Development and Pipeline Review, 2016 | Market Research Report By Hexa Reports

269. AVEO, OPHT: Recommendations

270. Ophthalmology Drug Industry Development and Pipeline Review, 2016 | Market Research Report By Hexa Reports

271. Global Ophthalmology Therapeutics Frontier Pharma Market Research Report 2016: Ophthalmology's Diverse Pipeline Could Rejuvenate Previously Stagnant Therapy Area

272. Macular Degeneration (AMD) and Other Retinal Diseases: World Drug Industry and Market 2016-2026

273. Global Age-related Macular Degeneration Market Growth of 7.37% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Vendors: Bayer Healthcare, Novartis, Alcon - Research and Markets

274. Age-Related Macular Degeneration - Market Trends and Forecasts: Technavio

279. DOCTORS' OF OPTOMETRY AMD ASSESSMENTS COMPARABLE TO OPHTHALMOLOGISTS

280. Retinal Diseases: Wet and Dry AMD, Diabetic Retinopathy Market 2016-2026: Aflibercept, Ranibizumab, Bevacizumab, Verteporfin, Ocriplasmin, Anti-VEGF, Anti-PDGF

281. Age Related Macular Degeneration Pipeline Landscape and Therapeutics Market 2016 Review

284. Global Age Related Macular Degeneration Therapeutics Report 2016 - Pipeline Review of 100+ Companies & Drug Profiles

285. Global Age-Related Macular Degeneration (AMD) Market Growth of 7.6% CAGR by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: Acucela, Bayer, Novartis - Research and Markets

286. Global Age-Related Macular Degeneration (AMD) Market Growth of 7.6% CAGR by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: Acucela, Bayer, Novartis

287. Global Age-Related Macular Degeneration (AMD) Market Growth of 7.6% CAGR by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: Acucela, Bayer, Novartis

288. Guidance and hope for people living with the most-common age-related vision problem

289. Guidance and hope for people living with the most-common age-related vision problem

290. Guidance and hope for people living with the most-common age-related vision problem

291. Global Ocular Disorders Overview - Rising Therapeutics, Technologies, and Devices - 200 Companies & 250 Clinical Trials - Research and Markets

292. Global Ocular Disorders Overview - Rising Therapeutics, Technologies, and Devices - 200 Companies & 250 Clinical Trials

293. Global Ocular Disorders Overview - Rising Therapeutics, Technologies, and Devices - 200 Companies & 250 Clinical Trials

294. USC ROSKI EYE INSTITUTE PUBLISHES FIRST STUDY TO ANALYZE AMD RISK, PREVALENCE AND IMPACT ON QUALITY OF LIFE FOR OLDER LATINOS

295. Global Age-Related Macular Degeneration Partnering Deals and Agreements 2010-2016 - Access to Headline, Upfront, milestone and royalty data

296. Global Age-Related Macular Degeneration Partnering 2010 to 2016 - Research and Markets

297. Global Age-Related Macular Degeneration Partnering 2010 to 2016

298. Global Age-Related Macular Degeneration Partnering 2010 to 2016

299. Macular Degeneration (AMD) and Other Retinal Diseases: World Drug Industry and Market 2016-2026

300. Nearly 3 out of 4 Americans Don't Know the Leading Cause of Blindness in People Over Age 60

Catalog

Books, media, physical & digital resources